(19)
(11) EP 4 444 911 A2

(12)

(88) Date of publication A3:
20.07.2023

(43) Date of publication:
16.10.2024 Bulletin 2024/42

(21) Application number: 22905191.7

(22) Date of filing: 09.12.2022
(51) International Patent Classification (IPC): 
C12Q 1/6869(2018.01)
G06T 7/00(2017.01)
G06T 7/246(2017.01)
G01N 15/14(2024.01)
C12Q 1/6872(2018.01)
G16B 25/10(2019.01)
G01N 33/49(2006.01)
G16B 15/00(2019.01)
(52) Cooperative Patent Classification (CPC):
G16B 30/00; G16B 40/10; G06T 7/33; G06T 2207/10064; G06T 2207/30024; C12Q 1/6869
 
C-Sets:
C12Q 1/6869, C12Q 2535/122, C12Q 2563/107;
(86) International application number:
PCT/US2022/052448
(87) International publication number:
WO 2023/107719 (15.06.2023 Gazette 2023/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 10.12.2021 US 202117547602
06.06.2022 US 202263349421 P
30.06.2022 US 202217854042
11.07.2022 US 202263388183 P

(71) Applicant: Element Biosciences, Inc.
San Diego, California 92121 (US)

(72) Inventors:
  • THOMPSON, Connor
    San Diego, California 92121 (US)
  • LIU, Tsung-li
    San Diego, California 92121 (US)
  • KRUGLYAK, Semyon
    San Diego, California 92121 (US)
  • GUO, Minghao
    San Diego, California 92121 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) PRIMARY ANALYSIS IN NEXT GENERATION SEQUENCING